Chaudhuri, Leena <br/><br/>
CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo.  [electronic resource] 

 -  Haematologica  Apr 2014 
 - 688-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2013.093187  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Ataxia Telangiectasia Mutated Proteins--antagonists & inhibitors<br/>Cell Cycle Proteins--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Checkpoint Kinase 1<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Gene Expression Profiling<br/>Gene Silencing<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Nuclear Proteins--antagonists & inhibitors<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Kinases--genetics<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrazoles--pharmacology<br/>Pyrimidines--pharmacology<br/>Pyrimidinones<br/>RNA Interference<br/>RNA, Small Interfering--genetics<br/>Signal Transduction<br/>Tumor Stem Cell Assay